Drugs and the renin-angiotensin system in covid-19

Clinical effects are unpredictable, so treatment decisions must be tailored and pragmatic

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ (Online) 2020-04, Vol.369, p.m1313-m1313
Hauptverfasser:	Aronson, Jeffrey K, Ferner, Robin E
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE inhibitors Angiotensin Angiotensin Receptor Antagonists - adverse effects Angiotensin Receptor Antagonists - pharmacology Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - pharmacology Angiotensin-Converting Enzyme Inhibitors - therapeutic use Betacoronavirus - drug effects Cardiology Coronavirus Infections - complications Coronavirus Infections - drug therapy Coronaviruses Councils COVID-19 Decision Making Drugs Duration of Therapy Enzymes Heart failure Humans Hypertension Hypertension - drug therapy Infections Pandemics Peptides Peptidyl-Dipeptidase A - drug effects Pneumonia, Viral - complications Pneumonia, Viral - drug therapy Practice Guidelines as Topic Renin Renin-Angiotensin System - drug effects Renin-Angiotensin System - physiology Severe acute respiratory syndrome coronavirus 2 Viral infections Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Clinical effects are unpredictable, so treatment decisions must be tailored and pragmatic
ISSN:	1756-1833 1756-1833
DOI:	10.1136/bmj.m1313